Synonyms: ABT-450 | ABT450 | veruprevir (deprecated INN) | Viekirax® (ombitasvir + paritaprevir + ritonavir; EU)
paritaprevir is an approved drug (FDA (2015), EMA (2020))
Compound class:
Synthetic organic
Comment: Paritaprevir is an orally bioavailable, direct-acting inhibitor of the hepatitis C virus (HCV) non-structural protein 3 and 4A (NS3/NS4A) protease complex [1]. It blocks NS3/NS4A protease-mediated polyprotein maturation, thus disrupting viral replication.
|
|
References |
1. Carrion AF, Gutierrez J, Martin P. (2014)
New antiviral agents for the treatment of hepatitis C: ABT-450. Expert Opin Pharmacother, 15 (5): 711-6. [PMID:24517400] |